| N-palmitoyl-D-glucosamine inhibits TLR-4/NLRP3 and improves DNBS-induced colon inflammation through a PPAR-α-dependent mechanism I Palenca, L Seguella, A Del Re, SB Franzin, C Corpetti, M Pesce, ... Biomolecules 12 (8), 1163, 2022 | 11 | 2022 |
| Mini-review: interaction between intestinal microbes and enteric glia in health and disease L Seguella, I Palenca, SB Franzin, A Zilli, G Esposito Neuroscience Letters 806, 137221, 2023 | 10 | 2023 |
| Oral Immunization with Escherichia coli Nissle 1917 Expressing SARS-CoV-2 Spike Protein Induces Mucosal and Systemic Antibody Responses in Mice G Sarnelli, A Del Re, M Pesce, J Lu, G Esposito, W Sanseverino, ... Biomolecules 13 (3), 569, 2023 | 8 | 2023 |
| Miconazole-like Scaffold is a Promising Lead for Naegleria fowleri-Specific CYP51 Inhibitors V Sharma, VN Madia, V Tudino, JV Nguyen, A Debnath, A Messore, ... Journal of Medicinal Chemistry 66 (24), 17059-17073, 2023 | 4 | 2023 |
| Intrarectal Administration of Adelmidrol plus Hyaluronic Acid Gel Ameliorates Experimental Colitis in Mice and Inhibits Pro-Inflammatory Response in Ex Vivo Cultured Biopsies … I Palenca, L Seguella, A Zilli, S Basili Franzin, A Del Re, F Pepi, A Troiani, ... International Journal of Molecular Sciences 25 (1), 165, 2023 | 2 | 2023 |
| Intranasal delivery of PEA-producing Lactobacillus paracasei F19 alleviates SARS-CoV-2 spike protein-induced lung injury in mice A Del Re, SB Franzin, J Lu, I Palenca, A Zilli, F Pepi, A Troiani, L Seguella, ... Translational Medicine Communications 9 (1), 9, 2024 | 1 | 2024 |
| Intranasal administration of Escherichia coli Nissle expressing the spike protein of SARS-CoV-2 induces long-term immunization and prevents spike protein-mediated lung injury … G Sarnelli, A Del Re, I Palenca, SB Franzin, J Lu, L Seguella, A Zilli, ... Biomedicine & Pharmacotherapy 174, 116441, 2024 | | 2024 |
| N‐palmitoyl‐d‐glucosamine limits mucosal damage and VEGF‐mediated angiogenesis by PPARα‐dependent suppression of pAkt/mTOR/HIF1α pathway and … I Palenca, S Basili Franzin, A Zilli, L Seguella, A Troiani, F Pepi, ... Phytotherapy Research, 2024 | | 2024 |
| Design and synthesis of brain permeable anti-Naegleria fowleri agents targeting CYP51 for primary amoebic meningoencephalitis treatment. VN Madia, D Ialongo, A Messore, E Patacchini, M Arpacioglu, V Tudino, ... IX EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry, 2023 | | 2023 |
| Miconazole-like compounds as brain permeable anti-Naegleria Fowleri agents targeting CYP51. VN Madia, D Ialongo, E Patacchini, A Messore, M Arpacioglu, V Tudino, ... 10th EFMC Young Medicinal Chemists' Symposium, 2023 | | 2023 |
| New blood-brain-barrier permeable compounds as Naegleria Fowleri CYP51 inhibitors. M Arpacioglu, VN Madia, D Ialongo, E Patacchini, A Messore, V Tudino, ... XXVIII edition of the National Meeting on Medicinal Chemistry, 2023 | | 2023 |
| PHARMACOGNOSY, PHYTOTHERAPY AND ENTERIC SYSTEM PHARMACOLOGY: INNOVATIVE APPROACHES FOR GREEN PHARMACOLOGICAL STRATEGIES A Vitalone, A DI SOTTO, S Di Giacomo, M Gullì, E Percaccio, L Seguella, ... La Facoltà di Farmacia e Medicina presenta le attività di ricerca …, 2023 | | 2023 |
